Lytgobi 4 mg, Filmtabletten
7680697140017
CH-69714
Filmtabletten
Associated product:
LYTGOBI cpr pellic 4 mg 21 pce
1 / 3
google
Article details
- Package size
- 21
- Selling units
- 21
- Measure
- Tablette(n)
- Galenic form
- Filmtabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
futibatinibum
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii laurilsulfas
|
- | Substance | HNIDK |
|
natrium
|
0.3196 MG | Substance | HBESI |
|
lactosum monohydricum
|
5.4 MG | Substance | HBESI |
|
maydis amylum
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
mannitolum
|
43.6 MG | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
macrogolum 6000
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
Taiho Oncology Europe GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 69714
- Drug name
- Lytgobi, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EN04
- Authorization status
- B
- Dispensing category
- A
- First authorization
- 08/10/2024
- Authorization expiration date
- 31/01/2028
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- LYTGOBI cpr pellic 4 mg 21 pce
- Description (DE)
- LYTGOBI Filmtabl 4 mg 21 Stk
- Market launch
- 31/12/2028
- Narcotic (BTM)
- No